Videos from 2015 American College of Cardiology Scientific Session
Watch experts from our NYU Langone Heart Programs discuss the latest findings in cardiovascular research and heart health at the 2015 American College of Cardiology Scientific Session.
New Study in NEJM Assesses Benefits of Stents Versus Bypass Surgery
Interventional cardiologist Dr. Sripal Bangalore discusses a new study from NYU Langone published in the New England Journal of Medicine, which found that newer drug-coated stents have similar long-term rates of death compared with traditional bypass surgery for patients.
“For patients and physicians, our study gives them up-to-date information as to which option to choose," Dr. Bangalore says. “Knowing the pros and cons will help them make an informed decision."
Air Pollution Levels Linked to Stroke-Related Narrowing of Arteries
Cardiologist Dr. Jonathan Newman discusses a new study from NYU Langone, which found that everyday air pollution is linked to a dangerous narrowing of neck arteries that occurs prior to strokes.
“If you have had heart disease or a stroke, it may be wise to avoid exposure and outdoor time on days when the air quality is very bad,” Dr. Newman says.
Study Finds Doctors Want to Learn More About Diet and Heart Disease Prevention
Preventive cardiologist Dr. Eugenia Gianos discusses the findings of a recent study, which revealed that doctors would welcome additional training in diet and nutrition so that they can effectively counsel patients about lifestyle changes and dietary choices.
“I’m fortunate to be a part of the NYU Langone Center for the Prevention of Cardiovascular Disease, where an emphasis is placed both on the most cutting-edge medications that are only available in clinical trials, as well as the importance of lifestyle and behavioral change,” Dr. Gianos says.
Treating Patients One Year After a Heart Attack
Cardiologist and vascular specialist Dr. Jeffrey Berger talks about the controversial results of the PEGASUS-TIMI 54 study, which looked at how best to treat patients one year after a heart attack.
“We’re getting into the area of precision medicine,” Dr. Berger says. “We’re learning how to treat individual patients, not populations.”
Calcification Shown on CT Scans Can Help Assess Cardiac Risk
Cardiologist and researcher Dr. Harmony Reynolds discusses a recent study about calcification of the coronary arteries found on routine chest CT scans, which is information that doctors can use for heart disease risk reduction.
“The bottom line for patients is, if you’ve had a CT scan, even if that CT scan was done for your lungs, your heart was included, so you should ask your doctor how the heart looked, and was there any coronary calcification,” Dr. Reynolds says.
Advances in Women's Heart Health
Dr. Nieca Goldberg, medical director of NYU Langone's Joan H. Tisch Center for Women’s Health, discusses recent findings about better diagnosing nonobstructive coronary artery disease in women who have had a heart attack.
“What I hope in the future is that we learn about whether or not certain drugs have more side effects in women versus men,” Dr. Goldberg says.
New Research from PROMISE Trial Shows Promise
Cardiologist Dr. Lawrence Phillips discusses new research from the PROMISE Trial (PROspective Multicenter Imaging Study for Evaluation of chest pain) assessing how to approach a patient with chest pain, and which test to use: anatomic CT or functional testing for screening for coronary artery disease.
“One of the best parts of the American College of Cardiology meeting is the focus on patients," Dr. Phillips says.
More Effective Class of Drugs to Lower Cholesterol
Preventive cardiologist Dr. Howard Weintraub discusses a new class of drugs developed rapidly over the past decade that more effectively lower LDL, or “bad” cholesterol, with fewer side effects than many other medications. He explains that the takeaway, though, is still that cardiovascular disease is ultimately preventable.
“One of the unique things that we have at NYU Langone is our Center for the Prevention of Cardiovascular Disease,” Dr. Weintraub says. “We offer an approach to the treatment of cardiovascular disease, particular prevention—primary and secondary prevention—which is really unequaled anywhere else."